• Je něco špatně v tomto záznamu ?

Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release

P. Chytil, M. Šírová, J. Kudláčová, B. Říhová, K. Ulbrich, T. Etrych,

. 2018 ; 15 (9) : 3654-3663. [pub] 20180321

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035351

Herein, the biodegradable micelle-forming amphiphilic N-(2-hydroxypropyl) methacrylamide (HPMA)-based polymer conjugates with the anticancer drug doxorubicin (Dox) designed for enhanced tumor accumulation were investigated, and the influence of their stability in the bloodstream on biodistribution, namely, tumor uptake, and in vivo antitumor efficacy were evaluated in detail. Dox was attached to the polymer carrier by a hydrazone bond enabling pH-controlled drug release. While the polymer-drug conjugates were stable in a buffer at pH 7.4 (mimicking bloodstream environment), Dox was released in a buffer under mild acidic conditions modeling the tumor microenvironment or cells. The amphiphilic polymer carriers differed in the structure of hydrophobic cholesterol derivative moieties bound to the HPMA copolymers via a hydrolyzable hydrazone bond, exhibiting different rates of micellar structure disintegration at various pH values. Considerable dependence of the studied polymer-drug conjugate biodistribution on the stability of the micellar structure was observed in neutral, bloodstream-mimicking, environment, showing that a faster rate of the micelle disintegration in pH 7.4 increased the conjugate blood clearance, decreased tumor accumulation, and significantly reduced the tumor:blood and tumor:muscle ratios. Similarly, the final therapeutic outcome was strongly affected by the stability of the micellar structure because the most stable micellar conjugate showed an almost similar therapeutic outcome as the water-soluble, nondegradable, high-molecular-weight starlike HPMA copolymer-Dox conjugate, which was highly efficient in the treatment of solid tumors in mice. Based on the results, we conclude that the bloodstream stability of micellar polymer-anticancer drug conjugates, in addition to their low side toxicity, is a crucial parameter for their efficient solid tumor accumulation and high in vivo antitumor activity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035351
003      
CZ-PrNML
005      
20191015105023.0
007      
ta
008      
191007s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.molpharmaceut.8b00156 $2 doi
035    __
$a (PubMed)29543465
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Chytil, Petr $u Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského náměstı́ 2 , 162 06 Prague 6 , Czech Republic.
245    10
$a Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release / $c P. Chytil, M. Šírová, J. Kudláčová, B. Říhová, K. Ulbrich, T. Etrych,
520    9_
$a Herein, the biodegradable micelle-forming amphiphilic N-(2-hydroxypropyl) methacrylamide (HPMA)-based polymer conjugates with the anticancer drug doxorubicin (Dox) designed for enhanced tumor accumulation were investigated, and the influence of their stability in the bloodstream on biodistribution, namely, tumor uptake, and in vivo antitumor efficacy were evaluated in detail. Dox was attached to the polymer carrier by a hydrazone bond enabling pH-controlled drug release. While the polymer-drug conjugates were stable in a buffer at pH 7.4 (mimicking bloodstream environment), Dox was released in a buffer under mild acidic conditions modeling the tumor microenvironment or cells. The amphiphilic polymer carriers differed in the structure of hydrophobic cholesterol derivative moieties bound to the HPMA copolymers via a hydrolyzable hydrazone bond, exhibiting different rates of micellar structure disintegration at various pH values. Considerable dependence of the studied polymer-drug conjugate biodistribution on the stability of the micellar structure was observed in neutral, bloodstream-mimicking, environment, showing that a faster rate of the micelle disintegration in pH 7.4 increased the conjugate blood clearance, decreased tumor accumulation, and significantly reduced the tumor:blood and tumor:muscle ratios. Similarly, the final therapeutic outcome was strongly affected by the stability of the micellar structure because the most stable micellar conjugate showed an almost similar therapeutic outcome as the water-soluble, nondegradable, high-molecular-weight starlike HPMA copolymer-Dox conjugate, which was highly efficient in the treatment of solid tumors in mice. Based on the results, we conclude that the bloodstream stability of micellar polymer-anticancer drug conjugates, in addition to their low side toxicity, is a crucial parameter for their efficient solid tumor accumulation and high in vivo antitumor activity.
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x chemie $x farmakokinetika $x terapeutické užití $7 D000970
650    _2
$a doxorubicin $x chemie $x farmakokinetika $x terapeutické užití $7 D004317
650    _2
$a nosiče léků $x chemie $7 D004337
650    _2
$a uvolňování léčiv $7 D065546
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a hydrofobní a hydrofilní interakce $7 D057927
650    _2
$a lymfom $x krev $x farmakoterapie $7 D008223
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a micely $7 D008823
650    _2
$a polymery $x chemie $7 D011108
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Šírová, Milada $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083 , 142 20 Prague 4 , Czech Republic.
700    1_
$a Kudláčová, Júlia $u Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského náměstı́ 2 , 162 06 Prague 6 , Czech Republic.
700    1_
$a Říhová, Blanka $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083 , 142 20 Prague 4 , Czech Republic.
700    1_
$a Ulbrich, Karel $u Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského náměstı́ 2 , 162 06 Prague 6 , Czech Republic.
700    1_
$a Etrych, Tomáš $u Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského náměstı́ 2 , 162 06 Prague 6 , Czech Republic.
773    0_
$w MED00008279 $t Molecular pharmaceutics $x 1543-8392 $g Roč. 15, č. 9 (2018), s. 3654-3663
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29543465 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191015105449 $b ABA008
999    __
$a ok $b bmc $g 1452011 $s 1073901
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 15 $c 9 $d 3654-3663 $e 20180321 $i 1543-8392 $m Molecular pharmaceutics $n Mol Pharm $x MED00008279
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...